Hi Dan!
I can provide you with 2 quick items that meet the statement of "do not bear dosage limitations" - the sunscreen monograph and the skin protectant monograph. Each of these monographs contains a statement that you can apply as often as necessary. So in other words - no limitation on how much to apply or any limitations on the number of applications per unit of time.
Think of this sort of situation - many skin protectants have the active ingredient petrolatum. There is no reason to believe that this active ingredient would degrade significantly over time. Additionally, there is no reason to limit the number of times that someone can reasonably use the active ingredient since it simply forms a barrier coating to protect the skin's moisture levels. So provided that the active ingredient stability (and all other essentials aspects of the formulation's stability) remain intact for 3 years or more (with proof via standard stability protocols for drugs) then the product would have the 3 year minimum shelf life to avoid actually having an expiration date listed on the package (I believe in the original labeling rule that established this section of 21 CFR that the FDA determined that it was highly unlikely that an OTC would not be used within a 3 year period but I don't have the reference for that one - sorry) and the skin protectant monograph allows for unlimited application amounts and frequency, so you don't require an expiration date.
------------------------------
Victor Mencarelli
Sr. Manager - Regulatory Affairs
Hain Celestial Group
United States
Original Message:
Sent: 05-Jul-2016 19:28
From: Dan O'Leary
Subject: Combination Product Expiration Dating
I’m a device guy, but my question is about Part 211 expiration dating in the context of a device/drug combination product. The regulation allows a CGMP operating system based on QSR with some sections from Part 211. One of them is §211.137 Expiration Dating which includes, §211,137(h), “Pending consideration of a proposed exemption, published in the Federal Register of September 29, 1978, the requirements in this section shall not be enforced for human OTC drug products if their labeling does not bear dosage limitations and they are stable for at least 3 years as supported by appropriate stability data”.
Can somebody give a simple explanation of a label that does “not bear dosage limitations”, the purpose of the regulatory discretion, and (since it has been waiting since 1978) the current status?
------------------------------
Dan O'Leary
Swanzey NH
United States
------------------------------